Golden Pear Funding, a national company in litigation finance for both pre-settlement and medical receivables, extended and upsized its investment-grade corporate notes to $78.7 million. Since its founding in 2008, Golden Pear has funded over $1.1 billion to more than 87,000 clients. Proceeds from the transaction will be used for flexible working capital and growth initiatives.
“This capital infusion is instrumental in our growth as we continue to provide financing for the rapidly expanding litigation finance market,” Gary Amos, CEO of Golden Pear, said. “We are grateful to have the backing of both our long-standing investor partners and new institutional supporters who share our vision.”
“The timing of this transaction aligns perfectly with our capital allocation strategy,” Daniel Amsellem, chief financial officer of Golden Pear, said. “These funds will be utilized to optimize our cost structure, enhance operational efficiency, and pursue strategic initiatives.”
Brean Capital served as the company’s exclusive financial advisor and sole placement agent in connection with the transaction.
